Abstract
Endogenous histamine has been shown to effect growth mechanisms in experimental mammary carcinomas via H2 membrane receptors (Cricco et al, 1994). Both H1 and H2 binding sites are present in human mammary glands but only 75% malignant carcinomas express H2 receptors (Lemos et al, 1995). The presence of mast cells around tumour tissue raises questions concerning the source of histamine in breast tumour tissue. While cimetidine, an H2 antagonist, has been shown to influence the presence of tumour infiltrating lymphocytes (TIL) in colorectal cancer (Adams and Morris, 1994, 1997) that was not found to be the case in breast cancer (Ng et al, 1995). In recent studies tumour cell proliferation, as measured by Ki-67 antibody labelling, has been seen as an additional prognostic indicator in breast cancer (Railo et al, 1993, 1997; Ferno, 1998; Schauer et al, 1998). We investigated the possibility that cimetidine may influence tumour proliferation by blocking the growth-promoting effects of histamine. No relationship between preoperative cimetidine administration and tumour cell proliferation was seen overall. A weak correlation was seen between tissue histamine content and mast cell count which was not influenced by cimetidine. Tumour cell proliferation correlated well with other prognostic indicators such as grade and differentiation. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Aaltomaa S, Lipponen P, Papinaho S and Kosma V-M (1993) Mast cells in breast cancer. Anticancer Res 13: 785–788
Adams WJ and Morris DL (1997) Pilot study – cimetidine enhances lymphocyte infiltration of human colorectal carcinoma. Cancer 80: 15–21
Adams WJ, Lawson JA and Morris DL (1994) Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 35: 1632–1636
Bouzubar N, Walker KJ, Griffiths K, Ellis IO, Elston CW, Robertson JFR, Blamey RW and Nicholson RI (1989) Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 59: 943–947
Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J and Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357–363
Cricco GP, Davio CA, Martin G, Engel N, Fitzsimons CP, Bergoc RM and Rivera ES (1994) Histamine as an autocrine growth factor in experimental mammary carcinomas. Agents Actions 43: 17–20
Davio CA, Cricco GP, Martin G, Fitzsimons CP, Bergoc RM and Rivera ES (1994) Effect of histamine on growth and differentiation of the rat mammary gland. Agents Actions 41: C115–C117
Davio C, Baldi A, Mladovan A, Cricco G, Fitzsimons C, Bergoc R and Rivera E (1995) Expression of histamine receptors in different cell lines derived from mammary gland and human breast carcinomas. Inflamm Res 44: S70–S71
Ferno M (1998) Prognostic factors in breast cancer: a brief review. Anticancer Res 18: 2167–2172
Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E and Flad H-D (1991) Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138: 867–873
Lemos B, Davio C, Gass H, Gonzalez P, Cricco G, Martin G, Bergoc R and Rivera E (1995) Histamine receptors in human mammary gland, different benign lesions and mammary carcinomas. Inflamm Res 44: S68–S69
Leonardi E, Girlando S, Serio G, Mauri FA, Perrone G, Scampini S, Dalla Palma P and Barbareschi M (1992) PCNA and Ki67 expression in breast carcinomas: correlations with clinical and biological variables. J Clin Pathol 45: 416–419
McCormick D, Yu C, Hobbs C and Hall PA (1993) The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens. Histopathology 22: 543–547
Ng WK, Vonthethoff LW, Magarey CJ, Adams WJ and Morris DL (1995) The effect of histamine antagonists on the presence of tumour infiltrating lymphocytes in breast cancer: a retrospective study. Surg Res Comm 18: 69–74
Railo M, Nordling S, von Boguslawsky K, Leivonen M Kyllonen L and von Smitten K (1993) Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer 68: 579–583
Railo M, Lundin J, Haglund C, von Smitten K, von Boguslawsky K and Nordling S (1997) Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer. Acta Oncologica 36: 369–374
Reynolds JL, Akhter JA, Magarey CJ, Schwartz P, Adams WJ and Morris DL (1998) Histamine in human breast cancer 8. Br J Surg 85: 538–541
Schauer A, Korabiowska M, Kellner S, Schumacher M, Sauer R, Bojar H and Rauschecker H (1998) Grading system for breast cancer. Anticancer Res 18: 2139–2144
Thomas M, Noguchi M, Kitagawa H, Kinoshita K and Miyazaki I (1993) Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma. J Clin Pathol 46: 525–528
Tubiana M and Courdi A (1989) Cell proliferation kinetics in human solid tumours: relation to probability of metastatic dissemination and long-term survival. Radiother Oncol 15: 1–18
Veronese SM and Gambacorta M (1991) Detection of Ki-67 proliferation rate in breast cancer: correlation with clinical and pathological features. Am J Clin Pathol 95: 30–34
Vielh P, Chevillard S, Mosseri V, Donatini B and Magdelenat H (1990) Ki67 index and S-phase fraction in human breast carcinomas: comparison and correlations with prognostic factors. Am J Clin Pathol 94: 681–686
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Bowrey, P., King, J., Magarey, C. et al. Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect?. Br J Cancer 82, 167–170 (2000). https://doi.org/10.1054/bjoc.1999.0895
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.0895
Keywords
This article is cited by
-
The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors
Cell Communication and Signaling (2022)
-
Non-random spatial relationships between mast cells and microvessels in human endometrial carcinoma
Clinical and Experimental Medicine (2017)
-
Spatial distribution of mast cells around vessels and glands in human gastric carcinoma
Clinical and Experimental Medicine (2017)
-
The Expression of Non-Mast Histamine in Tumor Associated Microvessels in Human Colorectal Cancers
Pathology & Oncology Research (2013)
-
The Tumor Microenvironment in Colorectal Carcinogenesis
Cancer Microenvironment (2010)